CA 125 ASSAY FOR THE ADVIA CENTAUR SYSTEM

Test, Epithelial Ovarian Tumor-associated Antigen (ca125)

BAYER CORP.

The following data is part of a premarket notification filed by Bayer Corp. with the FDA for Ca 125 Assay For The Advia Centaur System.

Pre-market Notification Details

Device IDK020828
510k NumberK020828
Device Name:CA 125 ASSAY FOR THE ADVIA CENTAUR SYSTEM
ClassificationTest, Epithelial Ovarian Tumor-associated Antigen (ca125)
Applicant BAYER CORP. 511 BENEDICT AVE. Tarrytown,  NY  10591 -5097
ContactKenneth T Edds
CorrespondentKenneth T Edds
BAYER CORP. 511 BENEDICT AVE. Tarrytown,  NY  10591 -5097
Product CodeLTK  
CFR Regulation Number866.6010 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2002-03-14
Decision Date2002-07-24
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00630414598116 K020828 000
00630414598109 K020828 000
00630414598093 K020828 000
00630414598086 K020828 000
00630414461335 K020828 000
00630414461304 K020828 000
00630414461298 K020828 000
00630414461274 K020828 000
00630414294278 K020828 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.